Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

119
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
119
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

69
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
69
  1. Home
  3. Research Domains
  5. Biomedical And Clinical Sciences
  7. Cardiovascular Medicine And Haematology
  9. Haematology
  11. Copeptin As A New Blood-based Marker For Differential Diagnosis In Stroke Patients

Copeptin as a New Blood-Based Marker for Differential Diagnosis in Stroke Patients

Antonia Ioana Vasile1,2, Sorin Tuță3,4, Cristina Tiu2,3

  • 1Doctoral School, Carol Davila University of Medicine and Pharmacy, 030167 Bucharest, Romania.

International Journal of Molecular Sciences
|June 13, 2025

Related Experiment Videos

Point of Care Transcranial Color-Coded Duplex Ultrasound of the Middle Cerebral Artery
04:01

Point of Care Transcranial Color-Coded Duplex Ultrasound of the Middle Cerebral Artery

Published on: August 9, 2024

609
Author Spotlight: Integrated Photoacoustic, Ultrasound, and Angiographic Tomography (PAUSAT) for NonInvasive Whole-Brain Imaging of Ischemic Stroke
06:45

Author Spotlight: Integrated Photoacoustic, Ultrasound, and Angiographic Tomography (PAUSAT) for NonInvasive Whole-Brain Imaging of Ischemic Stroke

Published on: June 2, 2023

1.3K
Quantification of Neurovascular Protection Following Repetitive Hypoxic Preconditioning and Transient Middle Cerebral Artery Occlusion in Mice
09:48

Quantification of Neurovascular Protection Following Repetitive Hypoxic Preconditioning and Transient Middle Cerebral Artery Occlusion in Mice

Published on: May 4, 2015

13.8K

View abstract on PubMed

Summary
This summary is machine-generated.

Copeptin, a novel blood marker, shows promise in diagnosing stroke and differentiating subtypes from mimics. Elevated copeptin levels aid in stroke diagnosis and prognosis, with normal levels excluding stroke.

Area of Science:

  • Neurology
  • Biomarkers
  • Clinical Diagnostics

Background:

  • Stroke diagnosis relies on clinical and radiological findings, necessitating reliable serological markers.
  • Copeptin is an emerging blood marker with potential diagnostic and prognostic value in various neurological conditions, including stroke subtypes and multiple sclerosis.

Purpose of the Study:

  • To evaluate the diagnostic utility of copeptin in distinguishing between different stroke subtypes and stroke mimics.
  • To assess copeptin's role in aiding clinical decision-making for acute neurological conditions.

Main Methods:

  • A comprehensive literature review was conducted using PubMed and Scopus databases.
  • Search terms included "stroke AND copeptin AND differential", adhering to PRISMA criteria.
  • Analysis focused on 29 original research articles in English, excluding reviews.
Keywords:
blood-based markercopeptindifferentialhemorrhagic stroke

Related Experiment Videos

Point of Care Transcranial Color-Coded Duplex Ultrasound of the Middle Cerebral Artery
04:01

Point of Care Transcranial Color-Coded Duplex Ultrasound of the Middle Cerebral Artery

Published on: August 9, 2024

609
Author Spotlight: Integrated Photoacoustic, Ultrasound, and Angiographic Tomography (PAUSAT) for NonInvasive Whole-Brain Imaging of Ischemic Stroke
06:45

Author Spotlight: Integrated Photoacoustic, Ultrasound, and Angiographic Tomography (PAUSAT) for NonInvasive Whole-Brain Imaging of Ischemic Stroke

Published on: June 2, 2023

1.3K
Quantification of Neurovascular Protection Following Repetitive Hypoxic Preconditioning and Transient Middle Cerebral Artery Occlusion in Mice
09:48

Quantification of Neurovascular Protection Following Repetitive Hypoxic Preconditioning and Transient Middle Cerebral Artery Occlusion in Mice

Published on: May 4, 2015

13.8K

Main Results:

  • All studies confirmed copeptin's ability to differentiate stroke patients from stroke-free individuals.
  • Some studies indicated significant correlations for differentiating stroke subtypes, while others found no significant differences.
  • Copeptin levels correlated with prognostic scales and could help exclude stroke in cases of vestibular disorders.

Conclusions:

  • Copeptin is a valuable blood marker for acute neurological care, assisting in stroke diagnosis and prognosis.
  • It aids in differentiating stroke subtypes and stroke mimics, though further research is required for definitive conclusions.
  • Normal copeptin levels may effectively rule out stroke, particularly in cases mimicking stroke symptoms.
ischemic stroke
stroke
stroke prognosis